Nicholas Thatcher - Concepedia

Author

Nicholas Thatcher

The Christie Hospital

Also Known As

N THATCHER, N Thatcher, N. THATCHER, N. Thatcher, Nicholas J. Thatcher, Nicholas Thatcher, Thatcher, N.

189

Publications

6.9K

Citations

H-Index

Concepts

All Affiliations

The Christie Hospital Cancer Research UK Manchester Institute Wythenshawe Hospital The Christie NHS Foundation Trust University of Manchester

About

Nicholas Thatcher is an author at The Christie Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	61	3.2K
2	Health Sciences	15	18	696
3	Biochemistry	2	2	139
4	Natural Sciences	1	1	53
5	Biostatistics	1	1	41

Nicholas Thatcher

Publications

5.3K

Citations

H-Index

Page 1

	Year	Citations
Phase III Trial Comparing Supportive Care Alone With Supportive Care With Oral Topotecan in Patients With Relapsed Small-Cell Lung Cancer Mary O’Brien, Tudor–Eliade Ciuleanu, H. Tsekov, Journal of Clinical Oncology	2006	628
Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer MH Bronchud, J.H. Scarffe, Nicholas Thatcher, British Journal of Cancer Phase I/ii StudyMedicineGranulocyteImmunologyIntensive Chemotherapy	1987	597
Temozolomide for the Treatment of Brain Metastases Associated With Metastatic Melanoma: A Phase II Study Sanjiv S. Agarwala, John M. Kirkwood, Martin Gore, Journal of Clinical Oncology	2004	356
Improving Survival Without Reducing Quality of Life in Small-Cell Lung Cancer Patients by Increasing the Dose-Intensity of Chemotherapy With Granulocyte Colony-Stimulating Factor Support: Results of a British Medical Research Council Multicenter Randomized Trial Nicholas Thatcher, D.J. Girling, Penelope Hopwood, Journal of Clinical Oncology G-csf SupportGood Performance StatusMedicineCancer ManagementPharmacology	2000	225
Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non–Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial Rodryg Ramlau, Tudor–Eliade Ciuleanu, Silvia Novello, Journal of Clinical Oncology	2012	185
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2 Peter Palmer, J. Vinke, Thierry Philip, Annals of Oncology Prognostic FactorsUrologyGenitourinary CancerMedicineImmune Checkpoint Inhibitor	1992	156
Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer Stuart C. White, Paul Lorigan, Geoffrey P. Margison, British Journal of Cancer	2006	149
A phase I study of intravenous bryostatin 1 in patients with advanced cancer J Prendiville, D. Crowther, Nicholas Thatcher, British Journal of Cancer Advanced CancerMedicineCancer ManagementPharmacologyPathology	1993	144
Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer Nicholas Thatcher, E S De Campos, David Bell, British Journal of Cancer	1999	128
Malignant melanoma in children and adolescents Charles B. Pratt, Michael K. Palmer, Nicholas Thatcher, Cancer Surgical OncologyTumoral PathologyPrimary LesionsMalignant DiseaseMedicine	1981	93

Page 1